These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 8275921

  • 1. [Randomized double-blind comparative study of the efficacy and tolerance of medifoxamine and imipramine in depressed patients].
    Olié JP, Galinowski A, Lehert P, Lemonnier F, Lôo H.
    Encephale; 1993; 19(4):333-40. PubMed ID: 8275921
    [Abstract] [Full Text] [Related]

  • 2. Minaprine and dose response in depression. An investigation of two fixed doses of minaprine compared with imipramine.
    Montgomery SA, Baldwin DS, Priest RG, Steinert J, Patel A, Herrington RN, Livingston HM.
    Pharmacopsychiatry; 1991 Sep; 24(5):168-74. PubMed ID: 1775522
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerance of femoxetine and imipramine in the treatment of depressive states. A randomized, double-blind study.
    Suominen J, Tamminen T, Elosuo R, Manniche PM.
    Pharmacopsychiatry; 1988 Sep; 21(5):238-44. PubMed ID: 3067246
    [Abstract] [Full Text] [Related]

  • 5. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
    Bohacek N, Ravic M, Bizière K.
    Drugs Exp Clin Res; 1987 Sep; 13(7):435-42. PubMed ID: 3308390
    [Abstract] [Full Text] [Related]

  • 6. Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine.
    Hebenstreit GF, Fellerer K, Fichte K, Fischer G, Geyer N, Meya U, Sastre-y-Hernández M, Schöny W, Schratzer M, Soukop W.
    Pharmacopsychiatry; 1989 Jul; 22(4):156-60. PubMed ID: 2668980
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK, van den Broek WW, Mulder PG, Moleman P, Bruijn JA.
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 9. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P, Touchon J, Billardon M.
    Encephale; 1997 Feb; 23(4):290-9. PubMed ID: 9417395
    [Abstract] [Full Text] [Related]

  • 10. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 11. Nefazodone in the treatment of severe, melancholic, and recurrent depression.
    Marcus RN, Mendels J.
    J Clin Psychiatry; 1996 Dec; 57 Suppl 2():19-23. PubMed ID: 8626359
    [Abstract] [Full Text] [Related]

  • 12. Multicenter double-blind comparison of nomifensine and imipramine for efficacy and safety in depressed outpatients.
    Bremner JD, Abrahams LM, Crupie JE, McCawley A, Proctor RC, Sathananthan GL.
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):56-9. PubMed ID: 6370976
    [Abstract] [Full Text] [Related]

  • 13. A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
    Feiger AD.
    Psychopharmacol Bull; 1996 Apr; 32(4):659-65. PubMed ID: 8993088
    [Abstract] [Full Text] [Related]

  • 14. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
    Daléry J, Aubin V.
    Encephale; 2001 Apr; 27(1):71-81. PubMed ID: 11294041
    [Abstract] [Full Text] [Related]

  • 15. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.
    Siwek M, Dudek D, Paul IA, Sowa-Kućma M, Zieba A, Popik P, Pilc A, Nowak G.
    J Affect Disord; 2009 Nov; 118(1-3):187-95. PubMed ID: 19278731
    [Abstract] [Full Text] [Related]

  • 16. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
    Niklson IA, Reimitz PE, Sennef C.
    Psychopharmacol Bull; 1997 Nov; 33(1):41-51. PubMed ID: 9133750
    [Abstract] [Full Text] [Related]

  • 17. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G, Saxena BM, Nair NP, Kutcher SP, Bakish D, Bradwejn J, Kennedy SH, Sharma V, Remick RA, Kukha-Mohamad SA.
    Clin Neuropharmacol; 1993 Nov; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG, Pritchett YL, Kajdasz DK, Bauer M, Jain R, Russell JM, Walker DJ, Spencer KA, Froud DM, Raskin J, Thase ME.
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10.
    Vorbach EU, Arnoldt KH, Hübner WD.
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():81-5. PubMed ID: 9342765
    [Abstract] [Full Text] [Related]

  • 20. Depressed in-patients respond differently to imipramine and mirtazapine.
    Bruijn JA, Moleman P, Mulder PG, van den Broek WW.
    Pharmacopsychiatry; 1999 May; 32(3):87-92. PubMed ID: 10463374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.